Skip to main content

    Roundup of Oncology/Pathology Talks

    ARVO 2023
    Comprehensive Ophthalmology, Ocular Pathology/Oncology

    Drs. Lauren Dalvin and Vivian Lee (ARVO Pathology/Oncology session Co-Chair) discuss highlights from the Pathology and Oncology session at ARVO 2023, including tumor characterization, the rapid evolution of treatments, and how understanding the mechanisms that lead to tumor genesis is the next frontier. One particularly exciting segment focused on a brand-new area of research involving extracellular vesicles within the eye. 

    Financial Disclosures: Dr. Lauren Dalvin discloses financial relationships with the Leonard and Mary Lou Hoeft Career Development Award Fund, National Cancer Institute, and National Center for Advancing Translational Science (Grant Support). Dr. Vivian Lee discloses a financial relationship with GlaxoSmithKline (Consultant/Advisor).